Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Nocturnal EnuresisEnuresisEnuresis, Nocturnal
Interventions
DRUG

Fluoxetine 20 MG

fluoxetine

DRUG

Desmopressin

desmopressin

Trial Locations (1)

63514

Faculty of medicine, Fayoum University, Al Fayyum

All Listed Sponsors
lead

Fayoum University Hospital

OTHER